Extravasation of vessicant antineoplastics: clinical and experimental findings.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D012871:Skin Diseases / Q000139:chemically induced
D000970:Antineoplastic Agents